Product Overview
Liver Infusion Agar (AS-1275) is a rich, non-selective solid medium specifically designed for the primary isolation, subculture, and maintenance
of extremely fastidious microorganisms — in particular, strict anaerobes and slow-growing bacterial pathogens that fail to grow or grow poorly
on conventional blood agar or standard peptone media. The medium derives its outstanding nutritional value from a concentrated liver tissue infusion,
which naturally provides hemin, vitamin K, NAD, essential amino acids, long-chain fatty acids, and biological reducing compounds,
generating a micro-environment of inherently low oxidation-reduction potential (Eh) that is hospitable to oxygen-sensitive organisms.
The deliberate exclusion of fermentable carbohydrates prevents inhibitory acid accumulation during extended incubation of up to 14 days.
The solidified agar matrix enables colony isolation, morphology assessment, and compatibility with overlay techniques such as the
egg-yolk (Nagler) reaction for Clostridium perfringens identification.
Intended Applications
- Primary isolation and subculture of strict anaerobes from clinical specimens (wound swabs, blood cultures, tissue biopsies, pus)
- Cultivation and propagation of Brucella spp. (with or without serum supplementation)
- Cultivation of Francisella tularensis under appropriate BSL-3 containment
- Maintenance of anaerobic stock cultures: Clostridium, Bacteroides, Fusobacterium, Actinomyces spp.
- Base medium for egg-yolk overlay (Nagler plates) for Clostridium perfringens lecithinase detection
- Base for special indicator or selective supplementation for anaerobic identification media
- Cultivation of nutritionally demanding streptococci and other fastidious organisms
Key Features
-
Natural liver infusion — hemin, vitamin K, NAD, amino acids, and biological reducing compounds
-
Superior to blood agar for many slow-growing and oxygen-injured anaerobes
-
Low carbohydrate content — minimal acid production; ideal for extended anaerobic incubation
-
Solid agar format — colony isolation, morphology assessment, and overlay compatibility
-
Flexible supplementation — compatible with blood, serum, hemin, vitamin K, and selective agents
Product Identification
| Product Name |
Liver Infusion Agar |
| Product Code |
AS-1275 |
| Synonyms |
Liver Agar; Liver Extract Agar |
| Grade |
Microbiological / Culture Media Grade |
| Format |
Dehydrated powder, beige to light tan |
| Quantity |
500 g per container |
| Storage (powder) |
15–30°C, dry, dark, tightly sealed |
| Shelf Life |
3 years from manufacture date |
| Intended Use |
Professional microbiological laboratory use only |
Composition (per litre prepared medium)
| Ingredient |
Quantity (g/L) |
Function |
| Liver Infusion Solids (from 250–500 g fresh liver) |
8.0–12.0 |
Hemin, vitamin K, NAD, reducing factors, growth factors, amino acids |
| Tryptose / Proteose Peptone |
10.0 |
Nitrogen & carbon source; peptides; amino acids |
| Sodium Chloride (NaCl) |
5.0 |
Osmotic balance |
| Bacteriological Agar |
15.0 |
Solidifying agent |
| Approximate total solids |
~40.0 g/L |
— |
Preparation
Suspend 40.0 g dehydrated medium in 1 litre purified water. Boil with agitation until agar is completely dissolved.
Autoclave at 121°C for 15 minutes. Cool to 45–50°C before adding heat-labile supplements
(blood, serum, hemin, vitamin K). Pour ~18–20 mL per 90 mm plate. For strict anaerobes, pour in anaerobic cabinet and
pre-reduce plates for ≥ 24 h before use. Final pH: 7.2 ± 0.2 at 25°C.
Incubation
| Temperature |
35–37°C |
| Anaerobes |
Strict anaerobic atmosphere: 85% N₂ / 10% CO₂ / 5% H₂ |
| Brucella / Francisella |
Capneic incubation: 5–10% CO₂ in air |
| Duration |
48 h minimum; up to 14 days for slow-growing organisms |
| Prepared plates — storage |
2–8°C in anaerobic bags; use within 4 weeks |
Disclaimer: This product is for professional microbiological laboratory use only.
AuSaMicS Pty Ltd reserves the right to modify specifications without prior notice.
For the most current version, visit
www.ausamics.com.au.
Section 1 — Identification
| Product Name |
Liver Infusion Agar |
| Product Code |
AS-1275 |
| Supplier |
AuSaMicS Pty Ltd | 31 Longview CT, Thomastown VIC 3074 | ABN: 56 676 640 467 |
| Phone |
+61 412 520 598 |
| Email |
support@ausamics.com |
| Emergency |
Poisons Information Centre (Australia): 13 11 26 (24 h) |
Section 2 — Hazard Identification
GHS Classification: NOT classified as a hazardous substance (dehydrated powder or prepared agar form, normal conditions of use).
Precautionary notes (not GHS hazards):
- Contains animal-derived liver infusion — apply institutional biosafety policies for animal-origin material
- Organisms cultivated may be BSL-2 or BSL-3 pathogens — comply with national and institutional biosafety regulations
- Treat all prepared/inoculated agar plates as potentially infectious — autoclave before disposal
- Agar powder may generate fine dust if handled carelessly — use P2/N95 for bulk dispensing
Section 3 — Composition
| Component |
Content (g/L) |
CAS Number |
GHS Classification |
| Liver Infusion Solids |
8.0–12.0 |
Not assigned (biological extract) |
Not classified |
| Tryptose / Proteose Peptone |
10.0 |
Not assigned (complex biological) |
Not classified |
| Sodium Chloride |
5.0 |
7647-14-5 |
Not classified at use concentration |
| Bacteriological Agar |
15.0 |
9002-18-0 |
Not classified |
Section 4 — First Aid
| Inhalation |
Remove to fresh air. Seek medical attention if symptoms persist. |
| Skin Contact |
Wash with soap and water. Remove contaminated clothing. Seek medical attention if irritation develops. |
| Eye Contact |
Flush immediately with water for ≥ 15 minutes, holding eyelids open. Seek immediate medical attention. |
| Ingestion |
Do not induce vomiting. Rinse mouth. Seek medical attention. Show this SDS to treating staff. |
Section 7 — Handling & Storage
| Handling |
Well-ventilated laboratory; avoid dust inhalation and contact with eyes/skin; follow GLP; use biosafety cabinet for inoculated plates |
| Powder storage |
15–30°C, original tightly sealed container, away from moisture, heat, and direct light |
| Prepared plates |
2–8°C in anaerobic bags or sealed containers; use within 4 weeks |
Section 8 — PPE
| PPE Type |
Specification |
| Gloves |
Nitrile or latex; double-glove for BSL-3 organisms |
| Eye / Face |
Safety glasses or goggles; face shield when aerosol/splash risk |
| Body |
Laboratory coat; impervious gown for culture work |
| Respiratory |
P2/N95 for bulk powder dispensing; not required for routine plate handling |
Section 13 — Disposal
-
Unused powder: Dispose as general laboratory waste per local regulations.
-
Uninoculated plates: Autoclave at 121°C / 30 min or dispose via licensed biological waste contractor.
-
Inoculated / contaminated plates: Autoclave at 121°C / 30 min (gravity cycle) before disposal as sterilised biological waste. Never dispose of unsterilised inoculated media in general waste or down the drain.
Section 14 — Transport
Not regulated as a dangerous good (ADG / IATA / IMDG) in dehydrated powder form. Keep upright and protect from moisture during transport.
Disclaimer: This SDS has been prepared in accordance with GHS (Rev. 7) and Safe Work Australia codes.
Information applies to the dehydrated product form only. All prepared and inoculated agar plates must be treated as potentially infectious.
AuSaMicS Pty Ltd | support@ausamics.com | +61 412 520 598 | ABN: 56 676 640 467.
Batch Identification
| Product Name |
Liver Infusion Agar |
| Product Code |
AS-1275 |
| Batch / Lot No. |
LIA-2026-001 |
| Manufacture Date |
March 2026 |
| Expiry Date |
March 2029 |
| Quantity Released |
500 g |
Physicochemical Testing
| Test Parameter |
Specification |
Result |
Status |
| Appearance (powder) |
Beige to light tan, homogeneous, free-flowing |
Beige, homogeneous, free-flowing |
✓ Pass |
| pH (25°C, prepared) |
7.0–7.4 |
7.2 |
✓ Pass |
| Appearance (prepared plate) |
Light amber, translucent, firm agar; no bubbles or cracks |
Light amber, firm, smooth |
✓ Pass |
| Gel formation |
Firm gel; no syneresis |
Firm gel, no liquid separation |
✓ Pass |
| Loss on Drying |
≤ 5.0% |
3.3% |
✓ Pass |
Microbiological Performance
| Organism |
ATCC No. |
Specification |
Result |
Status |
| Clostridium sporogenes |
11437 |
Good growth within 48–72 h (strict anaerobic) |
Good growth at 48 h |
✓ Pass |
| Bacteroides fragilis |
25285 |
Good growth within 48 h (strict anaerobic) |
Good growth at 48 h |
✓ Pass |
| Clostridium perfringens |
13124 |
Good growth within 24–48 h (anaerobic) |
Good growth at 24 h |
✓ Pass |
| Brucella abortus |
4315 |
Growth within 3–5 days (5–10% CO₂) |
Growth at day 4 |
✓ Pass |
| Uninoculated control |
— |
No growth at 48 h |
No growth |
✓ Pass |
Sterility Testing
| Method |
USP <71> Sterility — Membrane filtration / Direct inoculation |
| Incubation |
14 days at 20–25°C (FTM) and 30–35°C (SCDM) |
| Result |
No growth observed |
| Conclusion |
✓ PASS |
Release Conclusion
✓ BATCH RELEASED — ALL TESTS PASSED
Lot No. LIA-2026-001 meets all physicochemical, microbiological performance, and sterility specifications.
Disclaimer: This Certificate of Analysis is issued by AuSaMicS Pty Ltd for the specific batch indicated.
Results apply only to the tested batch. AuSaMicS Pty Ltd shall not be liable for results arising from improper storage, handling,
or use. ABN: 56 676 640 467 | support@ausamics.com | www.ausamics.com.au